Structure Therapeutics develops life‐changing medicines for patients using advanced structure-based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions. Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location. Reporting directly or operationally into the VP, Clinical Operations, the role supports the broader coordination of efforts across teams to ensure impactful contributions to AI integration Position Summary: The Director of Clinical AI Technologies is responsible for translating clinical operation needs into AI-driven solutions to lead the strategy, implementation, and scaling of artificial intelligence (AI) solutions that enhance the execution and performance of clinical trials. This role focuses on embedding AI into day-to-day C linical Develo p ment O perations to improve study delivery, site performance, patient enrollment/ engagement /retention , and data quality. As a leader within Clinical Development Operations, you will transform "AI potential" into "operational performance."
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
11-50 employees